Skip to content

Ionis Pharmaceuticals IONS Accrued Income Taxes, Current

Accrued Income Taxes, Current at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.09B-74.2%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Viatris logo
ViatrisVTRS
Merck & Co. logo
Merck & Co.MRK
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesCurrent.

The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's accrued income taxes, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ionis Pharmaceuticals's accrued income taxes, current?
Ionis Pharmaceuticals (IONS) reported accrued income taxes, current of $2.87M in Q1 2026.
How has Ionis Pharmaceuticals's accrued income taxes, current changed year-over-year?
Ionis Pharmaceuticals's accrued income taxes, current increased by 2181.0% year-over-year, from $126K to $2.87M.
What is the long-term trend for Ionis Pharmaceuticals's accrued income taxes, current?
Over 5 years (2020 to 2025), Ionis Pharmaceuticals's accrued income taxes, current has grown at a 15.4% compound annual growth rate (CAGR), from $1.32M to $2.71M.